DAIHAN Scientific Co., Ltd. (KOSDAQ:131220)
South Korea · Delayed Price · Currency is KRW 4,660.00
-55.00 (-1.17%)
At close: Mar 26, 2026
DAIHAN Scientific Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 81,118 | 71,694 | 73,702 | 72,280 | 66,281 |
Other Revenue | -0 | -0 | - | - | - |
| 81,118 | 71,694 | 73,702 | 72,280 | 66,281 | |
Revenue Growth (YoY) | 13.14% | -2.72% | 1.97% | 9.05% | 7.76% |
Cost of Revenue | 58,758 | 51,931 | 51,626 | 50,822 | 47,924 |
Gross Profit | 22,360 | 19,763 | 22,076 | 21,458 | 18,357 |
Selling, General & Admin | 14,204 | 13,096 | 13,435 | 12,316 | 10,721 |
Research & Development | 1,165 | 1,021 | 971.34 | 821.27 | 758.54 |
Amortization of Goodwill & Intangibles | 39.02 | 43.62 | 43.58 | 40.99 | 33.39 |
Other Operating Expenses | 350.02 | 343.33 | 335.52 | 253.68 | 243.08 |
Operating Expenses | 16,829 | 15,538 | 15,909 | 14,233 | 12,492 |
Operating Income | 5,531 | 4,225 | 6,167 | 7,224 | 5,865 |
Interest Expense | -42.06 | -95.56 | -151.32 | -53.51 | -42.46 |
Interest & Investment Income | 313.81 | 279.33 | 282.92 | 116.13 | 68.8 |
Earnings From Equity Investments | 3.24 | 16.4 | 4.68 | 22.11 | -12.27 |
Currency Exchange Gain (Loss) | -265.57 | -8.18 | -22.14 | 80.35 | 51.31 |
Other Non Operating Income (Expenses) | 51.3 | 116.6 | 172.93 | 160.1 | 204.58 |
EBT Excluding Unusual Items | 5,591 | 4,534 | 6,454 | 7,550 | 6,135 |
Gain (Loss) on Sale of Investments | -2.03 | -1.86 | -39.69 | - | - |
Gain (Loss) on Sale of Assets | 70.09 | 20.3 | 9.53 | -35.37 | -32.79 |
Pretax Income | 5,659 | 4,552 | 6,424 | 7,514 | 6,102 |
Income Tax Expense | 880.28 | 626.66 | 1,202 | 1,272 | 1,087 |
Earnings From Continuing Operations | 4,779 | 3,926 | 5,222 | 6,242 | 5,015 |
Minority Interest in Earnings | -1,498 | -1,233 | -1,377 | -1,540 | -1,248 |
Net Income | 3,281 | 2,693 | 3,845 | 4,702 | 3,767 |
Net Income to Common | 3,281 | 2,693 | 3,845 | 4,702 | 3,767 |
Net Income Growth | 21.87% | -29.98% | -18.22% | 24.81% | 120.39% |
Shares Outstanding (Basic) | 7 | 7 | 7 | 7 | 7 |
Shares Outstanding (Diluted) | 7 | 7 | 7 | 7 | 7 |
Shares Change (YoY) | -1.59% | -1.46% | -1.08% | -0.48% | -0.20% |
EPS (Basic) | 478.00 | 386.00 | 543.22 | 657.10 | 523.98 |
EPS (Diluted) | 478.00 | 386.00 | 543.00 | 657.00 | 523.98 |
EPS Growth | 23.83% | -28.91% | -17.35% | 25.39% | 121.09% |
Free Cash Flow | 5,128 | 3,547 | 4,169 | 1,474 | 939.76 |
Free Cash Flow Per Share | 747.07 | 508.52 | 588.88 | 205.94 | 130.71 |
Dividend Per Share | - | - | 60.000 | 60.000 | 60.000 |
Gross Margin | 27.57% | 27.57% | 29.95% | 29.69% | 27.70% |
Operating Margin | 6.82% | 5.89% | 8.37% | 9.99% | 8.85% |
Profit Margin | 4.04% | 3.76% | 5.22% | 6.50% | 5.68% |
Free Cash Flow Margin | 6.32% | 4.95% | 5.66% | 2.04% | 1.42% |
EBITDA | 7,312 | 6,065 | 8,005 | 8,913 | 7,416 |
EBITDA Margin | 9.01% | 8.46% | 10.86% | 12.33% | 11.19% |
D&A For EBITDA | 1,782 | 1,840 | 1,838 | 1,689 | 1,552 |
EBIT | 5,531 | 4,225 | 6,167 | 7,224 | 5,865 |
EBIT Margin | 6.82% | 5.89% | 8.37% | 9.99% | 8.85% |
Effective Tax Rate | 15.55% | 13.77% | 18.71% | 16.93% | 17.81% |
Advertising Expenses | 80.78 | 209.09 | 227.43 | 54.41 | 49.86 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.